3 completed, 1 recruiting, 1 unknown. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Unknown 1 |
Follow Probelte Pharma S.L.U.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Assess the Safety and Effectiveness of Beltaven® in Patients With Allergy to Apis Mellifera, Polistes Dominula or Vespula Spp. Allergy | Recruiting | Probelte Pharma S.L.U. | 27 | 2025-02-01 | 2025-12-30 | |
| Efficacy and Safety Assessment of Beltavac® With Polymerized Extract of HDM House dust mites allergoid from Dermatophagoides pteronyssinus and Dermatophagoides farinae, Placebo - House Dust Mite Allergy | Phase 3 | Unknown | Probelte Pharma S.L.U. | 350 | 2022-01-17 | 2024-07-18 |
| Study to Assess the Safety and Effectiveness of Beltavac® Polymerized With Cat Dander Beltavac® Polymerized with cat dander - Rhinoconjunctivitis With or Without Allergic Asthma | Completed | Probelte Pharma S.L.U. | 34 | 2019-12-01 | 2023-05-11 | |
| Study to Assess the Safety and Effectiveness of Beltavac® Polymerized With House Dust Mites Beltavac® Polymerized with house dust mites - Rhinoconjunctivitis With or Without Allergic Asthma | Completed | Alfons Malet i Casajuana | 97 | 2019-06-01 | 2023-05-25 | |
| Study to Assess the Safety and Effectiveness of Beltavac® Polymerized With Alternaria Alternata Beltavac® Polymerized with Alternaria alternata - Rhinoconjunctivitis With or Without Allergic Asthma | Completed | Probelte Pharma S.L.U. | 65 | 2018-06-07 | 2023-05-11 |
Dust Mite Allergy (1) · Hypersensitivity (1)
Antigens, Dermatophagoides (1)
Spain (5)